Vesicular Viral Vector Substitute (3VS) - Prototipazione e validazione di un dispositivo nanotecnologico vescicolare per terapia genica alternativa all’uso di vettori virali
Duration:
24/04/2023 - 23/10/2023
Principal investigator(s):
Project type:
Corporate-funded and donor-funded research
Funding body:
PRIVATI (Fondazione Compagnia di San Paolo)
Project identification number:
116208
PoliTo role:
Sole Contractor
People involved
- Tania Limongi (Principal Investigator)
- Francesca Susa (Component of the research team)
Structures
Keywords
ERC sectors
Sustainable Development Goals
Budget
| Total cost: | € 50,000.00 |
|---|---|
| Total contribution: | € 50,000.00 |
| PoliTo total cost: | € 50,000.00 |
| PoliTo contribution: | € 50,000.00 |